Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials

Clin Exp Allergy. 2022 Sep;52(9):1105-1109. doi: 10.1111/cea.14194. Epub 2022 Jul 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Chronic Disease
  • Humans
  • Nasal Polyps* / complications
  • Nasal Polyps* / drug therapy
  • Patient Reported Outcome Measures
  • Quality of Life
  • Rhinitis* / complications
  • Rhinitis* / drug therapy
  • Sinusitis* / complications
  • Sinusitis* / drug therapy
  • Smell

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab

Associated data

  • ClinicalTrials.gov/NCT02898454
  • ClinicalTrials.gov/NCT02912468